| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
58,973 |
53,110 |
$5.01M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
28,284 |
27,081 |
$2.00M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
46,441 |
46,283 |
$1.31M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33,260 |
33,095 |
$1.24M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
33,246 |
33,077 |
$1.24M |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
32,605 |
32,483 |
$1.21M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
40,705 |
36,265 |
$1.05M |
| 81513 |
|
7,622 |
7,499 |
$951K |
| 87481 |
|
9,377 |
8,287 |
$679K |
| 99000 |
|
79,416 |
75,783 |
$556K |
| 88307 |
|
4,114 |
4,026 |
$467K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12,054 |
11,900 |
$452K |
| 88312 |
|
10,297 |
9,856 |
$344K |
| 88342 |
|
2,622 |
2,540 |
$197K |
| 88304 |
|
7,430 |
7,272 |
$192K |
| 88141 |
|
7,169 |
7,129 |
$171K |
| 87625 |
|
3,446 |
3,442 |
$143K |
| 88341 |
|
1,302 |
1,206 |
$132K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,176 |
5,689 |
$111K |
| 87660 |
|
4,631 |
4,592 |
$95K |
| 87480 |
|
4,607 |
4,568 |
$95K |
| 87510 |
|
4,595 |
4,557 |
$94K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,057 |
449 |
$88K |
| 85060 |
|
1,686 |
1,665 |
$39K |
| 88142 |
|
1,628 |
1,625 |
$35K |
| 88112 |
|
946 |
879 |
$32K |
| S9999 |
Sales tax |
4,090 |
4,014 |
$31K |
| 87511 |
|
441 |
439 |
$17K |
| 88311 |
|
917 |
881 |
$16K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
463 |
453 |
$12K |
| 88302 |
|
647 |
643 |
$8K |
| 88300 |
|
463 |
458 |
$5K |